Clinical Trials Browser

INDUSTRY × GDC-0084 × Clear all

NCT03522298 2025-03-24

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Phase 2 Completed

30 enrolled 27 charts

Glioblastoma

NCT01547546 2016-11-02

A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

Phase 1 Completed

Glioblastoma, Glioma